Overview
IHE market data
Price History
IHE price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- — Diluted earnings per share over the trailing twelve months.
- Beta
- 0.50 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $64.94 – $103.70 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap —.
Company news
Two Years to Build or Pay 200% — Which US Pharma Stocks Win?Benzinga · Jul 24, 2026, 10:25 AM
Which ETF Is Healthier for Your Portfolio: Vanguard Health Care ETF or iShares Pharmaceuticals ETF?The Motley Fool · Jul 22, 2026, 9:15 PM
iShares U.S. Pharmaceuticals ETF Tops Simplify Health Care ETF ReturnsThe Motley Fool · Jun 10, 2026, 7:15 PM
GLP-1 Drugs Powered IHE's Big Year. IXJ Is Playing a Longer Game.The Motley Fool · May 27, 2026, 4:15 PM
Bristol-Myers Squibb-Anthropic AI Deal Targets Faster Drug DiscoveryBenzinga · May 20, 2026, 5:15 PM